CVS' pharmacy segment continues to lead the industry, processing over 1.7 billion prescriptions annually while delivering ...

CVS Health's stock price received a positive prognosis from Truist Financial, boosting the target from $82 to $84. The ...

Today's Research Daily features new research reports on 16 major stocks, including Oracle Corp. (ORCL), IBM Corp. (IBM) and ...

The stock market is highly volatile. Amid this uncertainty, income investors are seeking stability. Dividend stocks provide ...

UnitedHealth has faced several headwinds in the recent past, ranging from a cyberattack, which had greater than initially ...

Novo Nordisk (NVO) announced a new $2.2 billion deal with San Francisco-based biotech Septerna (SEPN) for obesity pills — the ...

This edition of Market Factors provides top stock picks in health care, a sector that has historically combined high profit ...

On May 13, 2025, UnitedHealth Group announced a seismic leadership change: CEO Andrew Witty resigns for “personal reasons,” ...

The deal with U.S. biotech Septerna will see the companies develop pills to treat obesity, type 2 diabetes and other cardiometabolic diseases. Surging medical costs and regulatory changes hit ...

Discover CV Sciences' Q1 2025 highlights: revenue of $3.6M, improved margins, product innovation, & M&A-driven cost efficiency.

Bristol Myers Squibb President Benjamin Hickey recently cashed out a modest $3,701 in stock, barely enough for a luxury ...